Evidence map›Paper›PMID 39231312›Full record

ArticleBlood advances2024

Plasmin generation analysis in patients with bleeding disorder of unknown cause.

Dino Mehic, Stéphanie E Reitsma, Claire de Moreuil, Helmuth Haslacher, Maximilian C Koeller, Bas de Laat, Cihan Ay, Ingrid Pabinger, Alisa S Wolberg, Johanna Gebhart

Abstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. Review
  5. Altered clot structure in pregnant women who will develop postpartum hemorrhage.Research and practice in thrombosis and haemostasis · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dino MehicDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Stéphanie E ReitsmaDepartment of Pathology and Laboratory Medicine, UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.ORCID 0000-0002-7058-5038
Claire de MoreuilDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-1142-0978
Helmuth HaslacherDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-4605-2503
Maximilian C KoellerDepartment of Pathology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9699-3390
Bas de LaatDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-9596-1944
Cihan AyDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2607-9717
Ingrid PabingerDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Alisa S WolbergDepartment of Pathology and Laboratory Medicine, UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Johanna GebhartDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4578-3120

Funding

Fibrinogen and Factor XIII in Venous ThrombosisR01HL126974 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alisa S. Wolberg · 2016 to 2026
$4.4M
NHLBI NIH HHS R01 HL126974
6 · The paper itself

Abstract

abstractBleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion after evaluation of plasma coagulation and platelet function. Patients with BDUC (n = 375) recorded in the Vienna Bleeding Biobank were analyzed in comparison with healthy controls (HCs; n = 100) in this case-control study. Plasmin generation (PG) parameters were analyzed using calibrated fluorescence detection in citrated plasma. Turbidimetric plasma clot formation/lysis of 293 (78%) patients with BDUC and confocal microscopy of clots from representative patients with BDUC (n = 6) and HCs (n = 9) were assessed. In the PG analysis, patients with BDUC exhibited lower velocity and peak plasmin levels but a higher endogenous plasmin potential than HCs. Peak plasmin levels correlated with maximum clot absorbance but not with clot lysis time. Clot absorbance is an indicator of clot fiber density. Confocal microscopy analysis revealed a tendency towards thicker fibers in clots of patients with BDUC, which negatively correlated with peak plasmin (r = -0.561; P = .030). Peak plasmin correlated weakly with factor XIII, but not with other fibrinolytic factors (alpha2-antiplasmin, thrombin activatable fibrinolysis inhibitor, or plasminogen activator inhibitor 1) or bleeding severity. A model comprising fibrinogen and parameters of PG yielded high predictive power in discriminating between patients with BDUC and HCs across a fivefold stratified cross validation (80% of data; mean area under the curve [AUC], 0.847). The model generalized well to unseen data (20% of data; AUC, 0.856). Overall, patients with BDUC counterintuitively exhibited reduced peak plasmin levels, potentially related to altered clot structure.

Indexed as

FibrinolysinAdultAgedBlood CoagulationBlood Coagulation TestsCase-Control StudiesFemaleFibrinolysisHemorrhagic DisordersHumansMaleMiddle AgedFibrinolysin

Identifiers

PMID39231312
PMCPMC11564053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.